Semaglutide

FDA APPROVED

Fda Approved

Weight

Metabolic

Semaglutide

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Learn more

Weight

Semaglutide

Metabolic

Amino acid sequence

31

Amino acids

4da

Molecular weight

Peptide

Type

Long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Over 17,000 trial participants have demonstrated significant efficacy through appetite suppression and glycemic control. The 7-day half-life enables convenient weekly dosing.

Top researched benefits

Overview of Semaglutide

Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways.

weight loss

  • FDA-approved for chronic weight management with average 15-20% body weight loss in clinical trials.
  • Reduces hunger and food cravings through central nervous system GLP-1 receptor activation.
  • Long-term studies show maintained weight loss with continued treatment over 2+ years.

diabetes

  • FDA-approved for type 2 diabetes with HbA1c reductions of 1.5-2% in clinical trials.
  • Proven 26% reduction in cardiovascular death, MI, or stroke in high-risk diabetes patients.
  • Improves insulin secretion and may preserve pancreatic beta cell function.

metabolic

  • Addresses multiple components: weight, glucose, blood pressure, and lipids.
  • Emerging evidence for improvements in non-alcoholic fatty liver disease.
  • Decreases systemic inflammation markers independent of weight loss.

Typical Dose

0.25mg starting, titrate to 1-2.4mg weekly

Frequency

Once weekly (same day each week)

Cycle Duration

Ongoing therapy as prescribed

Storage

Pen: 2-8°C before first use, room temp up to 56 days after. Compounded: 2-8°C

Chemical Makeup

Key benefits

15-20% average body weight reduction

Established cardiovascular protection

Convenient once-weekly dosing options

Comprehensive safety data from extensive trials

Flexible injectable and oral formulations

Community interest

This peptide is still gaining traction in the community.

GLP-1 Receptor Agonist | Weight Loss & Diabetes

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Semaglutide Molecular Information

View the scientifc details of Semaglutide.

31

Amino Acids

Semaglutide

His

His

Position 1

Sec

Sec

Position 2

Glu

Glu

Position 3

Gly

Gly

Position 4

Thr

Thr

Position 5

Phe

Phe

Position 6

Thr

Thr

Position 7

Ser

Ser

Position 8

Asp

Asp

Position 9

Val

Val

Position 10

Ser

Ser

Position 11

Ser

Ser

Position 12

Tyr

Tyr

Position 13

Leu

Leu

Position 14

Glu

Glu

Position 15

Gly

Gly

Position 16

Gln

Gln

Position 17

Ala

Ala

Position 18

Ala

Ala

Position 19

Lys

Lys

Position 20

Glu

Glu

Position 21

Phe

Phe

Position 22

Ile

Ile

Position 23

Ala

Ala

Position 24

Trp

Trp

Position 25

Leu

Leu

Position 26

Val

Val

Position 27

Arg

Arg

Position 28

Gly

Gly

Position 29

Arg

Arg

Position 30

Gly

Gly

Position 31

Amino acid sequence
HistidinePosition 1
SelenocysteinePosition 2
Glutamic acidPosition 3
GlycinePosition 4
ThreoninePosition 5
PhenylalaninePosition 6
ThreoninePosition 7
SerinePosition 8
Aspartic acidPosition 9
ValinePosition 10
SerinePosition 11
SerinePosition 12
TyrosinePosition 13
LeucinePosition 14
Glutamic acidPosition 15
GlycinePosition 16
GlutaminePosition 17
AlaninePosition 18
AlaninePosition 19
LysinePosition 20
Glutamic acidPosition 21
PhenylalaninePosition 22
IsoleucinePosition 23
AlaninePosition 24
TryptophanPosition 25
LeucinePosition 26
ValinePosition 27
ArgininePosition 28
GlycinePosition 29
ArgininePosition 30
GlycinePosition 31

Molecular Weight

4Da

Chain Length

31Amino Acids

Type

Peptide

Semaglutide Protocols

Pre-filled pen devices for once-weekly subcutaneous injection. Brands include Ozempic (diabetes) and Wegovy (weight loss).

GoalDosageFrequencyRoute
Weight Loss Initiation0.254 week rangeSubcutaneous
Weight Loss Maintenance2.416 week rangeSubcutaneous
Diabetes Management0.5Subcutaneous
Cardiovascular Protection0.5Subcutaneous
Tolerability-Based0.25Subcutaneous

Reconstitution Instructions

Materials needed:

Semaglutide pre-filled pen or vialPen needles (if using pen device)Alcohol swabsSharps disposal containerInjection site rotation chart

Steps to reconstitute

  1. If using pre-filled pen, attach new needle and prime per instructions
  2. If using vial, draw prescribed dose with appropriate syringe
  3. Clean injection site with alcohol swab and let dry
  4. Inject subcutaneously at 90-degree angle (45-degree if lean)
  5. Hold for 6 seconds after injection to ensure full dose delivery
  6. Dispose of needle safely and rotate injection sites weekly

Semaglutide Cycle

The Semaglutide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-4
Mild appetite reduction, possible nausea during initial dose
Month 2-3
Noticeable weight loss (5-10% typical), improved satiety
Month 4-6
Continued weight loss (10-15% common), stable glucose levels
Week 0-0
Weight loss plateau possible, focus on maintenance
Week 0-0
Blood sugar improvements within 1-2 weeks

Dosing tools

Semaglutide Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Semaglutide

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Semaglutide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Semaglutide
Dosing
0.25mg starting, titrate to 1-2.4mg weekly
Dosing Frequency
Once weekly (same day each week)
Cycle Duration
Ongoing therapy as prescribed
Storage
Pen: 2-8°C before first use, room temp up to 56 days after. Compounded: 2-8°C

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Semaglutide interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No contraindications; may help with GI side effects.

COMPATIBLE

Weight

cag

Metabolic

Cagrilintide

SYNERGISTIC

Combined as CagriSema in clinical trials for enhanced weight loss efficacy.

SYNERGISTIC

Side effects

Contraindications

Personal or family history of medullary thyroid cancer

Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Pregnancy or breastfeeding

History of pancreatitis

Stop signs

Severe persistent abdominal pain (possible pancreatitis)

Persistent vomiting preventing fluid intake

Signs of thyroid tumor (neck lump, hoarseness, trouble swallowing)

Severe allergic reaction (rash, itching, difficulty breathing)

Vision changes (possible diabetic retinopathy progression)

Severe hypoglycemia (if combined with insulin/sulfonylureas)

Kidney problems (decreased urination, swelling)

Bad signs

Cloudy or discolored solutionParticles or precipitation visibleNon-pharmacy sources or unverified online sellers
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

SemaglutideResearch References

Semaglutide is a fda approved compound

6Research references

Semaglutide

Semaglutide is a fda approved compound

STEP 1 Trial - Weight Management

14.9% average weight loss versus 2.4% with placebo over 68 weeks with 2.4mg weekly.

2021

SELECT Cardiovascular Outcomes

20% reduction in major adverse cardiovascular events over 5 years with 2.4mg weekly.

2023

SUSTAIN Diabetes Program

Average HbA1c reductions of 1.5-1.8% across multiple trials.

2016

STEP 5 Two-Year Maintenance

Sustained weight loss of 15.2% at week 104 with 2.4mg weekly.

2022

PIONEER Oral Semaglutide

Oral efficacy comparable to injectable formulations at 3-14mg daily.

2019

STEP TEENS Adolescent Study

16.1% BMI reduction in adolescent population over 68 weeks.

2022